4-41745975-TGCCGCCGCTGCCGCTGCCGCC-TGCCGCCGCTGCCGCTGCCGCCGCCGCCGCTGCCGCTGCCGCC
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_003924.4(PHOX2B):c.776_777insGGCGGCAGCGGCAGCGGCGGC(p.Ala254_Ala260dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A259A) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 8.8e-7 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PHOX2B
NM_003924.4 inframe_insertion
NM_003924.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.60
Genes affected
PHOX2B (HGNC:9143): (paired like homeobox 2B) The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM1
In a region_of_interest Disordered (size 30) in uniprot entity PHX2B_HUMAN there are 10 pathogenic changes around while only 3 benign (77%) in NM_003924.4
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-41745975-T-TGCCGCCGCTGCCGCTGCCGCC is Pathogenic according to our data. Variant chr4-41745975-T-TGCCGCCGCTGCCGCTGCCGCC is described in ClinVar as [Pathogenic]. Clinvar id is 452239.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHOX2B | NM_003924.4 | c.776_777insGGCGGCAGCGGCAGCGGCGGC | p.Ala254_Ala260dup | inframe_insertion | 3/3 | ENST00000226382.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHOX2B | ENST00000226382.4 | c.776_777insGGCGGCAGCGGCAGCGGCGGC | p.Ala254_Ala260dup | inframe_insertion | 3/3 | 1 | NM_003924.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 8.77e-7 AC: 1AN: 1140480Hom.: 0 Cov.: 31 AF XY: 0.00000181 AC XY: 1AN XY: 551176
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1140480
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
551176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neuroblastoma, susceptibility to, 2;C5562075:Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 08, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 31, 2023 | Duplication of 7 alanine residues in the second polyalanine tract, resulting in a total of 27 alanine residues.; Polyalanine repeat expansion of 26 or more repeats have been reported in association with congenital central hypoventilation syndrome (PMID: 20301600; 20208042); Published functional evidence indicate that expanded PHOX2B protein forms ubiquitin positive inclusions, which sequester wild-type PHOX2B, resulting in reduced transcriptional and binding activity of wild-type protein and possibly supporting a dominant-negative effect (PMID 22307522; 23103552); De novo variant with confirmed parentage in a patient with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease previously tested at GeneDx and as an apparently de novo variant in multiple patients in the published literature with CCHS (PMID: 12640453; 15121777); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23231723, 22437207, 18079495, 30850150, 12640453, 15121777, 20456320, 15860752, 22307522, 20301600, 20208042) - |
PHOX2B-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 11, 2024 | The PHOX2B c.756_776dup21 variant is predicted to result in an in-frame duplication (p.Ala254_Ala260dup). This variant has previously been reported in multiple individuals with congenital central hypoventilation syndrome (CCHS) (Serra et al. 2010. PubMed ID: 20456320). This duplication causes an expansion of the polyalanine repeat region from 20 repeats (normal) to 27 repeats; repeat expansions of similar size have been documented to be causative for CCHS (Lai and Schroer. 2008. PubMed ID: 18230845; Trivedi et al. 2011. PubMed ID: 21076974). This variant is not present in a large population database and has been interpreted as Pathogenic in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/452239/). Taken together, we interpret this variant as pathogenic. - |
Congenital central hypoventilation Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This variant is located within the polyalanine tract in exon 3 of the PHOX2B gene and causes an in-frame duplication resulting in an expansion event. An alternative nomenclature for this variant is p.Ala241[27], which corresponds to a 27 polyalanine repeat expansion (PMID: 20301600). Repeat expansions within the polyalanine tract in the PHOX2B gene are an established mechanism of disease and have been previously reported in patients with Congenital Central Hypoventilation Syndrome (PMID: 12640453, 14566559, 14608649, 15121777). This variant has been previously reported as a heterozygous change in multiple individuals with Congenital Central Hypoventilation Syndrome (PMID: 20456320). It is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating that this variant likely occurred as a de novo event. Based on the available evidence, the c.756_776dup (p.Ala254_Ala260dup) variant is classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at